Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E35.10 EPS (ttm)1.68 Insider Own- Shs Outstand2.08B Perf Week1.97%
Market Cap122.76B Forward P/E27.17 EPS next Y2.17 Insider Trans- Shs Float1.42B Perf Month6.35%
Income4.40B PEG2.15 EPS next Q- Inst Own9.80% Short Float0.23% Perf Quarter3.15%
Sales13.78B P/S8.91 EPS this Y8.00% Inst Trans-0.35% Short Ratio2.78 Perf Half Y34.39%
Book/sh1.81 P/B32.57 EPS next Y18.32% ROA41.30% Target Price71.10 Perf Year30.04%
Cash/sh0.51 P/C116.52 EPS next 5Y16.30% ROE81.30% 52W Range41.08 - 59.49 Perf YTD41.50%
Dividend0.73 P/FCF57.78 EPS past 5Y23.30% ROI65.50% 52W High-0.89% Beta1.02
Dividend %1.24% Quick Ratio0.70 Sales past 5Y11.70% Gross Margin84.00% 52W Low43.54% ATR0.92
Employees39062 Current Ratio1.00 Sales Q/Q23.90% Oper. Margin40.50% RSI (14)57.87 Volatility1.07% 1.09%
OptionableYes Debt/Eq0.02 EPS Q/Q55.60% Profit Margin31.80% Rel Volume1.33 Prev Close58.28
ShortableYes LT Debt/Eq0.00 EarningsAug 06 BMO Payout44.80% Avg Volume1.15M Price58.96
Recom1.00 SMA202.76% SMA503.63% SMA20018.81% Volume1,536,985 Change1.17%
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Feb-08-08Upgrade Bernstein Mkt Perform → Outperform
Jul-30-15 06:23PM  Six International Leaders Preparing To Report Results at Investor's Business Daily
Jul-24-15 11:12AM  AbbVie: Beware the Biosimilars? at
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. PR Newswire
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. CNW Group
Jul-16-15 12:18PM  Novo Nordisk says Flexpro PenMate gets FDA approval Reuters
Jul-15-15 09:48AM  Greece Is On The Verge Of A Health Catastrophe at Forbes
Jul-13-15 01:50PM  Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog
Jul-10-15 12:59PM  Novo Nordisk's new GLP-1 diabetes drug hits goal in trial +5.31%
Jul-07-15 03:50PM  Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog
01:04PM  Is This Novo Nordisk's Next Blockbuster Drug? at Motley Fool
Jul-02-15 12:00PM  Novo Nordisk Halts Sale of Tresiba Insulin in Germany Over Pricing Dispute at The Wall Street Journal
Jul-01-15 12:15PM  The Greek debt crisis turned these European stocks into even better buys at Fortune
09:24AM  Status regarding Novo Nordisk's holding of its own shares (30 June 2015) Thomson Reuters ONE
Jun-29-15 04:45PM  Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog
Jun-25-15 11:17AM  Conquering Hemophilia: Novo Nordisk Reports Encouraging Data From Phase III Trial Of NovoEight
Jun-24-15 06:15PM  Cramer: Getting down to BAX's Biz
Jun-22-15 03:17PM  Top Europe Stocks Rally On Greece Bailout Hopes at Investor's Business Daily
Jun-17-15 08:21PM  Edited Transcript of NOVO B.CO corporate analyst meeting
Jun-09-15 07:24AM  Novo Nordisk A/S upgraded by Morgan Stanley
Jun-08-15 03:35PM  Novo Nordisk Reveals New Findings from Additional Studies - Analyst Blog
Jun-07-15 08:00AM  Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
03:00AM  New Xultophy® (IDegLira) Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change and Lower Rate of Hypoglycaemia Versus Insulin Glargine CNW Group
May-28-15 10:06AM  19 kids and cancelled: TV shows that got pulled due to controversy at Fortune
May-27-15 07:05PM  Is This Diabetes Stock a Better Bet Than MannKind? at Investopedia
May-25-15 12:50PM  Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog
May-20-15 12:08PM  Novo Nordisk, Baxter clash over haemophilia drug patent Reuters
10:52AM  Novo Nordisk rejects Baxter patent claim over Novoeight Reuters
10:40AM  China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR Newswire
May-18-15 04:59PM  SLU vs. Bothell: The region's two hot biotech real estate markets go head to head at
May-17-15 11:36AM  Billionaire Jim Simons Top Holdings: Inc. (AMZN), Colgate-Palmolive Company and More at Insider Monkey
May-14-15 09:35AM  UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner at Insider Monkey
May-08-15 04:21PM  Healthcare Winners and Losers: May 8, 2015
May-06-15 06:00AM  Hot Drugs Show Sharp Price Hikes in Shadow Market
06:00AM  Diabetes Drugs Compete With Prices That Rise in Lockstep at Bloomberg
May-05-15 01:16PM  Healthcare Mid-Day Winners and Losers: May 05, 2015
12:51PM  Healthcare AM Winners and Losers: May 05, 2015
12:46PM  Healthcare AM Winners and Losers: May 04, 2015
12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
12:46PM  Healthcare Winners and Losers: May 04, 2015
May-04-15 03:41PM  Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog
May-03-15 11:28PM  Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE
01:26PM  5 Trade Ideas for Monday: Fastenal, Goodyear, Northern Trust, Novo Nordisk & NXP Semi
Apr-30-15 06:50PM  Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
10:48AM  Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings at Investor's Business Daily
07:08AM  European drugmakers lifted by weak euro at Financial Times
Apr-22-15 11:44AM  Economic Sentiment up in the Eurozone: EWG up 0.88%, FEZ up 0.46%
11:27AM  Novo launches Saxenda in US, sees more launches in 2015 Reuters
10:38AM  Novo Nordisk says Saxenda obesity drug to cost $1,068 per month
09:23AM  3 Large-Cap Pharmaceutical Companies to Invest in Right Now at TheStreet
Apr-13-15 05:09PM  Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog
Apr-09-15 01:40PM  Novo Nordisk's Tresiba & Ryzodeg NDAs under FDA Review - Analyst Blog
Apr-01-15 02:46PM  Hedge Funds Made A Bundle By Betting On, Inc. (AMZN), Apple, and Pfizer Inc at Insider Monkey
10:40AM  FDA Urged to Fine Drugmakers Over Ads at Fox Business
08:01AM  Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 March 2015) Globe Newswire Europe
Mar-31-15 03:43PM  Top First Quarter European ETFs
Mar-30-15 07:00AM  The Best and Worst Medalists of 2015's First Quarter at Morningstar
Mar-29-15 06:17PM  Novo Nordisks Insulin Move Is Right Medicine at The Wall Street Journal
Mar-27-15 11:39PM  Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons Holdings for Long-Run at Insider Monkey
06:15PM  Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog
03:10PM  Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog
02:18PM  Insulin: moving the needle at Financial Times
01:15PM  European stocks snap win streak; DAX logs first weekly loss in 2 months at MarketWatch
11:19AM  Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source Reuters
11:06AM  European shares set for 2015's biggest weekly fall despite Novo Nordisk surge Reuters
09:40AM  Novo Nordisk's Insulin Move Is Right Medicine at The Wall Street Journal
08:13AM  Can The Uptrend Continue for Novo Nordisk (NVO)? - Tale of the Tape
07:39AM  Novo Nordisk surge buoys European shares after two-day slide Reuters
07:39AM  March 27 Premarket Briefing: 10 Things You Should Know
07:25AM  Cruise news you can use, plus more Friday business headlines at
06:10AM  European Stocks Rebound From Two-Day Drop
04:41AM  Novo Nordisk Soars on Plan to Resubmit Rejected Insulin in U.S. at Bloomberg
Mar-26-15 06:49PM  Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog +6.90%
06:40PM  Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
06:36PM  Red Hat, Signet Top Buy Points En Route To New Highs at Investor's Business Daily
04:01PM  Novo Nordisk (NVO) Stock Gains Today on Drug Application Resubmission at TheStreet
01:57PM  Novo Nordisk to Refile Tresiba in the U.S. on Interim Analysis at Bloomberg
11:46AM  The Investor's Solution to Low, Low Interest Rates: Part I at Forbes
08:55AM  Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog
Mar-24-15 01:40PM  Novo Nordisk's Saxenda Gets EU Approval for Obesity - Analyst Blog
08:47AM  Bristol-Myers in Autoimmune Program Deal at The Wall Street Journal
Mar-19-15 04:10PM  Pfizer Announces Publication of CAPiTA Data on Prevenar 13 - Analyst Blog
10:38AM  Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better" at Forbes
Mar-18-15 05:10PM  Valeant (VRX) Prices Shares to Finance Salix Acquisition - Analyst Blog
03:38PM  AstraZeneca Presents Encouraging Heart Drug Brilinta Data - Analyst Blog
02:20PM  Novartis' Jakavi Gets EC Approval for Polycythemia Vera - Analyst Blog
10:53AM  Novo Nordisk A/S - Share repurchase programme at noodls
Mar-17-15 12:17AM  Weight-Loss Drugs Seek Acceptance From Patients and Physicians at The Wall Street Journal
Mar-16-15 01:17PM  Weight-Loss Drugs Try Again at The Wall Street Journal
Mar-09-15 05:06PM  Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog
Mar-06-15 03:16AM  Novo Nordisk A/S gennemfører succesfuld børsnotering af NNIT A/S at noodls
Feb-23-15 05:23PM  Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog
Feb-20-15 11:42AM  Novo Nordisk Pops On Successful Diabetes Drug Trial at Investor's Business Daily +5.27%
Feb-12-15 01:40PM  Baxter Announces Positive Data for BAX 855; Competition Rife - Analyst Blog
Feb-06-15 09:00AM  On MannKind, Diabetics Have One Up On Wall Street at Forbes
Feb-05-15 10:47AM  Novo Nordisk files annual report with the SEC at noodls
Feb-03-15 09:47PM  Sale of Seattle BioMed, Juno building sets Seattle price record at
07:00AM  Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-02-15 09:46AM  Novo Nordisk's Q4 Earnings Rise Y/Y, Provides 2015 Outlook - Analyst Blog Zacks
Jan-30-15 08:59AM  Diabetics: Use Your Firsthand Experience To Beat Wall Street at Forbes
Jan-28-15 06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.